Evidence map›Paper›PMID 36817060›Full record

ArticleOncology letters2023

Effect of pelvic radiotherapy on patients with stage IB‑IIA cervical cancer after radical hysterectomy: A single‑center retrospective study.

Chihiro Ishizawa, Ayumi Taguchi, Michihiro Tanikawa, Harunori Honjo, Akira Nishijima, Satoko Eguchi, Yuichiro Miyamoto, Kenbun Sone, Tetsushi Tsuruga, Mayuyo Mori and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Chihiro IshizawaDepartment of Obstetrics and Gynecology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Ayumi TaguchiDepartment of Obstetrics and Gynecology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Michihiro TanikawaDepartment of Obstetrics and Gynecology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Harunori HonjoDepartment of Obstetrics and Gynecology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Akira NishijimaDepartment of Obstetrics and Gynecology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Satoko EguchiDepartment of Obstetrics and Gynecology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Yuichiro MiyamotoDepartment of Obstetrics and Gynecology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Kenbun SoneDepartment of Obstetrics and Gynecology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Tetsushi TsurugaDepartment of Obstetrics and Gynecology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Mayuyo MoriDepartment of Obstetrics and Gynecology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Yutaka OsugaDepartment of Obstetrics and Gynecology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
University of Tokyo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effects of post-operative adjuvant radiotherapy (RT) on intermediate-risk patients with cervical cancer have not been fully elucidated. Therefore, the present study aimed to investigate the impact of RT on intermediate-risk cervical cancer. The data of 112 patients with stage IB and IIA cervical cancer treated with radical hysterectomy between January 2009 and December 2018 were retrospectively reviewed. Overall survival (OS), progression-free survival (PFS), and the frequency of adverse events were compared between patients with and without adjuvant RT (RT

Indexed as

adjuvant radiotherapycervical cancerhysterectomyintermediate-risk group

Identifiers

PMID36817060
PMCPMC9932628
OpenAlexW4318997613

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.